3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Polycystic Ovary Syndrome
6
Squamous Cell Carcinoma of Head and Neck
2
Obesity
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Laryngeal Diseases
1
Insulin Resistance
1
Inflammation
1
Head and Neck Squamous Cell Cancer
1
Head and Neck Neoplasms
1
Glioblastoma
1
Diabetes Mellitus
1
Barrett Esophagus
1
Interventions
olaparib
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
fludarabine
3
X-Rays
2
Taxes
2
Platinum
2
Paclitaxel
2
Oncolytic Virotherapy
2
Letrozole
2
Hyperthermic Intraperitoneal Chemotherapy
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Cytoreduction Surgical Procedures
2
Cisplatin
2
Carboplatin
2
Aspirin
2
1,2-diaminocyclohexaneplatinum II citrate
2
trastuzumab biosimilar HLX02
1
sodium thiosulfate
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
niraparib
1
montelukast
1
gallium 68 PSMA-11
1
eribulin
1
entrectinib
1
cobimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Ovarian Neoplasms
×
Metformin
×
Clear all
NCT03378297
2024-10-30
IMPACT
Haukeland University Hospital
Phase EARLY_PHASE1
Completed
26 enrolled